Nutranomics, Inc.
$0.00$0.00 (0.0%)
Nutranomics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
OTC · MEDD · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Medical Imaging Corp.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Medical Imaging Corp. (MEDD), operating through its various subsidiaries across North America, provides a comprehensive array of diagnostic imaging solutions for a diverse clientele, including individual patients, healthcare facilities, workers' compensation organizations, and insurance carriers. The company also specializes in teleradiology, offering remote analysis and reporting for medical scans. Its robust service portfolio encompasses modalities such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), ultrasound, nuclear medicine, digital mammography, X-ray, and bone mineral densitometry. As of the end of 2017, its physical operations included a standalone diagnostic imaging center in Pottsville, Pennsylvania, in addition to three diagnostic facilities located throughout Florida. Established in 2000 and headquartered in Las Vegas, Nevada, the enterprise adopted its current name, Medical Imaging Corp., in July 2014, having previously operated as Diagnostic Imaging International Corp.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Nutranomics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
West Island Brands Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Itoco Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
$0.00$0.00 (0.0%)
Decision Diagnostics Corp.’s quoted price sits in the lower half of its reported 52-week range, 33.77% below the high.
$0.00$0.00 (0.0%)
Filament Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 99.5% below the high.
$0.00$0.00 (0.0%)
PrimeMD Inc’s quoted price sits in the lower half of its reported 52-week range, 98.99% below the high.
$0.00$0.00 (0.0%)
Veritas Farms, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.83% below the high.
$0.00-$0.00 (-50.0%)
Endonovo Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.